Recurrent pregnancy loss: Clinical evidence for suboptimal implantation

Infertility and Reproductive Medicine Clinics of North America

Volumn 12, Issue 2, 2001, Pages 447-461

  Stephenson, M D ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MATERNAL AGE; NATURAL KILLER CELL; NIDATION; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; REPRODUCTION; REVIEW; SPONTANEOUS ABORTION; X CHROMOSOME INACTIVATION;

EID: 0035074995     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Cytotoxic HLA antibodies: Immunoglobulin classification
2. Preconceptional natural-killer-cell activity as a predictor of miscarriage
3. Protective antibodies and spontaneous abortion
4. Cytogenetic diagnosis of "normal 46, XX" karyotypes in spontaneous abortions frequently may be misleading
5. Reprospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions
6. Reproductive failure due to spontaneous abortion and recurrent miscarriage
7. Treatment of recurrent aborters by immunization with paternal cells: Controlled trial
8. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions with i.v. immunoglobulin
9. An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases
10. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: A histomorphometric study
11. Intravenous immunoglobulin for treatment of recurrent pregnancy loss
12. Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials
13. Predictors for livebirth after unexplained spontaneous abortion: Correlations between immunologic test results, obstetric histories, and outcome of next pregnancy without treatment
14. Endometrial receptivity: Cell biological aspects of an unusual epithelium. A review
15. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
16. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro
17. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: Results of a controlled trial
18. Intravenous immunoglobulin for treatment of recurrent miscarriage
19. Immunogenetics of spontaneous abortions in humans
20. Thirty-four fertilized human ova, good, bad and indifferent, recovered from 210 women of known fertility; A study of biologic wastage in early human pregnancy
21. Evidence of embryo and trophoblast toxic cellular immune responses(s) in women with recurrent spontaneous abortion
22. Immunotherapy for recurrent spontaneous abortion in a Chinese population
23. Terminological conventions, methodological considerations, temporal trends, specific genes, environmental hazards and some other factors pertaining to embryonic and fetal deaths
24. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: A double-blind placebo-controlled study
25. Chromosome abnormalities: Origin and etiology in abortions and livebirths
26. Screening for cytokine MRNAs in human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction (RT-PCR)
27. On the nature and function of human uterine granular lymphocytes
28. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions
29. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion
30. The X chromosome and recurrent spontaneous abortion: The significance of transmanifesting carriers
31. Comparative genomic hybridization in combination with flow cytometry improves results of cytogenetic analysis of spontaneous abortions
32. In search of the "missing self": MHC molecules and NK cell recognition
33. Gene action in the X-chromosome of the mouse
34. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells
35. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin
36. Mononuclear cell immunization in prevention of recurrent miscarriage: A randomised trial
37. A cytogenetic study of spontaneous abortions with direct analysis of chorionic villi
38. Short-term therapy for recurrent abortion using intravenous immunoglobulins: Results of a double-blinded placebo-controlled Italian study
39. Chromosome analysis of spontaneous abortions after IVF. A European survey
40. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies
41. Influence of past reproductive performance on risk of spontaneous abortion
42. Characteristics of women with recurrent miscarriage and skewed X-chromosome inactivation
43. Fetal loss rates and their relation to pregnancy order
44. Antiphospholipid antibodies-lobsters or red herrings?
45. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion
46. Trisomy 21 mosaicism in gonads with unexpectedly high recurrence risks
47. Extremely skewed X-chromosome inactivation is increased in women with recurrent spontaneous abortion
48. Incidence and timing of pregnancy losses: Relevance to evaluating safety of early prenatal diagnosis
49. Frequency of factors associated with habitual abortion in 197 couples
50. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: A prospective, randomized, double-blind, placebo-controlled trial
51. Spontaneous abortion risks in man: Data from reproductive histories collected in a medical genetics unit
52. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
53. Timing of implantation of the conceptus and loss of pregnancy
54. Incidence of early loss of pregnancy
55. Mechanism of intravenous immune globulin therapy in antibody mediated autoimmune diseases